|
|
|
|
Fuelzyme-LF™" enzyme improves the efficiency and economics of ethanol production. Developed and marketed by Verenium, this new product increases the throughput of corn solids by increasing viscosity reduction at a higher temperatures and broader pH ranges than currently available. By providing superior liquefaction ethanol producers are able to realize increased ethanol output without having to invest in any additional capital expenditures. More >>
|
|
|
|
|
Syngenta is developing a transgenic version of a alpha-amylase enzyme discovered under a collaboration with Verenium. The added advantage of this enzyme is to allow the starch in corn to "self-process" as an aid in the cost effective production of ethanol and other products. More>>
|
|
UNDER DEVELOPMENT
In U.S. Regulatory Review
Estimated U.S. Launch: 2008
|
|
|
Verenium has developed the Purifine™ brand of enzymes for the conversion of vegetable oils to biodiesel, an alternative fuel. More >>
|
|
|
|
|
Verenium is developing a collection of enzymes capable of converting corn biomass to cellulosic ethanol and other chemicals. More>>
|
SYNGENTA
DUPONT
ICBR
NEW ZEALAND
|
UNDER DEVELOPMENT
|
|
|
|
|
|
|
|
|
|
|
|
|
Luminase™ PB-100 enzyme enhances the reactivity of pulp fiber to bleaching, allowing mills to achieve desired pulp brightness while reducing the use of harsh bleaching chemicals. More >> |
|
LAUNCHED NORTH AMERICA
LAUNCHED EUROPE
|
|
|
Luminase PB-200 enzyme is the next-generation, highly thermostable xylanase that improves pulp bleaching over broader process conditions. More >>
|
|
LAUNCHED NORTH AMERICA
LAUNCHED EUROPE
|
|
|
Verenium has developed the Purifine™ brand of enzymes to aid in processing oil seed in the production of edible oil. More >> |
|
UNDER DEVELOPMENT
In U.S. Regulatory Review
Estimated U.S. Launch: 2007
|
|
|
Pyrolase™ 160 and Pyrolase™ 200 enzymes are broad spectrum, high temperature and high pH, ß-mannanases which can be employed in a variety of industrial applications. More >>
|
|
LAUNCHED
|
|
|
|
|
|
|
|
|
Phyzyme™-XP enzyme, one of the two thermostable phytase enzymes developed by Verenium, has been shown to improve animal health while reducing phosphate pollution by making phosphorus, a key nutritional mineral, more available in feed. It is marketed by Danisco. More >>
|
|
LAUNCHED U.S.
LAUNCHED EUROPE
|
|
|
Quantum phytase, a thermostable phytase enzyme developed in collaboration with and marketed by Syngenta, has been shown to lead to healthier, more robust animals while reducing phosphate content in manure. More >>
|
|
LAUNCHED OUS
In Regulatory U.S.
|
|
|
Verenium is developing with its partner Syngenta a transgenic version of a phytase to aid in cost effective production of the enzyme.
|
|
|
|
|
The BAYOVAC®-SRS vaccine, marketed by Bayer, was genetically engineered to prevent salmonoid rickettsial septicemia (SRS) in farmed Atlantic salmon. SRS is a deadly infectious disease affecting the Chilean salmon industry, which produces about 45 percent of the world's farmed salmon. More>>
|
|
|
|
|
|
|
Verenium is improving an Anti-CD3 antibody for superior potency and reduced immunogenicity vs. the current OKT-3 for bone marrow transplantation. More>>
|
|
UNDER DEVELOPMENT
(PARTNERSHIP OPPORTUNITY)
|
|
|
Under the Rapid Antibody-Based Biological Countermeasures (RAbBC) program for the DoD, Verenium is generating multiple new, enhanced antibody candidates to diagnose and neutralize anthrax infections. More>>
|
|
|
|
|
Verenium, with a grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is discovering and developing antibodies to diagnose and treat Severe Acute Respiratory Syndrome (SARS). More>>
|
|
|
|
|
|
|
